Article Information
History
- October 23, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Kristin L. Andrejko, BS1,*,
- Jake Pry, PhD2,*,
- Jennifer F. Myers, MPH2,
- John Openshaw, MD2,
- James Watt, MD, MPH2,
- Nozomi Birkett, BS2,
- Jennifer L. DeGuzman, MPH2,
- Sophia S. Li2,
- Camilla M. Barbaduomo2,
- Anna T. Fang2,
- Vivian H. Tran2,
- Mahsa H. Javadi, MD2,
- Paulina M. Frost2,
- Zheng N. Dong2,
- Seema Jain, MD2,†,
- Joseph A. Lewnard, PhD1,3,4,† and
- on behalf of the California COVID-19 Case-Control Study Team§
- 1Division of Epidemiology and Biostatistics, School of Public Health, University of California, Berkeley, California, United States
- 2California Department of Public Health, Richmond, California, United States
- 3Division of Infectious Diseases & Vaccinology, School of Public Health, University of California, Berkeley, California, United States
- 4Center for Computational Biology, College of Engineering, University of California, Berkeley, California, United States
- ↵†Joint corresponding authors: Joseph A. Lewnard, PhD, 2121 Berkeley Way, Berkeley, California 94720, United States, Tel.: +1 (510) 664-4050, E-mail: jlewnard{at}berkeley.edu, Seema Jain, MD, 850 Marina Bay Parkway, Richmond, California 94804, United States, Tel.: +1 (510)-620-3444, E-mail: Seema.Jain{at}cdph.ca.gov
↵* KA and JP contributed equally to the study.
Posted October 23, 2021.
